Search research articles
Contact Us
Filters
Showing results (131-140 of 512) with videos related to
Page
of 52
Sort By:
Carcinogenesis
|
March 1, 1996
Characterization of bacterial cytochrome cd(1)-nitrite reductase as one enzyme responsible for catalysis of nitrosation of secondary amines
S Calmels, H Ohshima, Y Henry, et al.
Carcinogenesis
|
November 1, 1983
Hydroxylation and nitroreduction are required to activate dimethylnitramine into alkylating and mutagenic agents
C Malaveille, A Croisy, G Brun, et al.
Gene
|
May 20, 1997
The nuclear autoantigen La/SS-B: mapping and sequencing of the gene and the three retropseudogenes
D Grölz, H Bartsch, H Tröster, et al.
IARC Scientific Publications
|
January 1, 1993
Immunoaffinity clean-up combined with 32P-postlabelling analysis of 1,N6-ethenoadenine and 3,N4-ethenocytosine in DNA
Y Guichard, J Nair, A Barbin, et al.
Nature
|
June 19, 1975
Tissue-mediated mutagenicity of vinylidene chloride and 2-chlorobutadiene in Salmonella typhimurium
H Bartsch, C Malaveille, R Montesano, et al.
Mutation Research
|
August 1, 1975
Proceedings: Comparative mutagenicity studies with S. typhimurium of dimethylnitrosamine (DMN) and diethylnitrosamine (DEN), after metabolic activation with liver and lung microsomes
C Malaveille, M Camus, R Montesano, et al.
Cancer Letters
|
September 1, 1983
Presence in human urine of a new N-nitroso compound, N-nitrosothiazolidine 4-carboxylic acid
H Ohshima, M Friesen, I O'Neill, et al.
Cancer Research
|
April 1, 1982
Mutagenic and alkylating activities of 3-methyl-1-phenyltriazenes and their possible role as carcinogenic metabolites of the parent dimethyl compounds
C Malaveille, G Brun, G Kolar, et al.
Nucleic Acids Research
|
January 24, 1981
Studies on the miscoding properties of 1,N6-ethenoadenine and 3,N4-ethenocytosine, DNA reaction products of vinyl chloride metabolites, during in vitro DNA synthesis
A Barbin, H Bartsch, P Leconte, et al.
Onkologie
|
March 8, 2003
Cancer-related fatigue in patients attending oncological rehabilitation programs: prevalence, patterns and predictors
H H Bartsch, J Weis, M T Moser
Page
of 52
Search research articles
Search
Showing results (131-140 of 512) with videos related to
Sort By:
Page
of 52
Carcinogenesis
|
March 1, 1996
Characterization of bacterial cytochrome cd(1)-nitrite reductase as one enzyme responsible for catalysis of nitrosation of secondary amines
S Calmels, H Ohshima, Y Henry, et al.
Carcinogenesis
|
November 1, 1983
Hydroxylation and nitroreduction are required to activate dimethylnitramine into alkylating and mutagenic agents
C Malaveille, A Croisy, G Brun, et al.
Gene
|
May 20, 1997
The nuclear autoantigen La/SS-B: mapping and sequencing of the gene and the three retropseudogenes
D Grölz, H Bartsch, H Tröster, et al.
IARC Scientific Publications
|
January 1, 1993
Immunoaffinity clean-up combined with 32P-postlabelling analysis of 1,N6-ethenoadenine and 3,N4-ethenocytosine in DNA
Y Guichard, J Nair, A Barbin, et al.
Nature
|
June 19, 1975
Tissue-mediated mutagenicity of vinylidene chloride and 2-chlorobutadiene in Salmonella typhimurium
H Bartsch, C Malaveille, R Montesano, et al.
Mutation Research
|
August 1, 1975
Proceedings: Comparative mutagenicity studies with S. typhimurium of dimethylnitrosamine (DMN) and diethylnitrosamine (DEN), after metabolic activation with liver and lung microsomes
C Malaveille, M Camus, R Montesano, et al.
Cancer Letters
|
September 1, 1983
Presence in human urine of a new N-nitroso compound, N-nitrosothiazolidine 4-carboxylic acid
H Ohshima, M Friesen, I O'Neill, et al.
Cancer Research
|
April 1, 1982
Mutagenic and alkylating activities of 3-methyl-1-phenyltriazenes and their possible role as carcinogenic metabolites of the parent dimethyl compounds
C Malaveille, G Brun, G Kolar, et al.
Nucleic Acids Research
|
January 24, 1981
Studies on the miscoding properties of 1,N6-ethenoadenine and 3,N4-ethenocytosine, DNA reaction products of vinyl chloride metabolites, during in vitro DNA synthesis
A Barbin, H Bartsch, P Leconte, et al.
Onkologie
|
March 8, 2003
Cancer-related fatigue in patients attending oncological rehabilitation programs: prevalence, patterns and predictors
H H Bartsch, J Weis, M T Moser
Page
of 52